Date | Time | Source | Announcement |
---|---|---|---|
10 May 2005 | 07:00 AM | Transaction in Own Shares | |
06 May 2005 | 04:15 PM | Director Shareholding | |
06 May 2005 | 09:00 AM | AGM Resolutions | |
06 May 2005 | 07:00 AM | Transaction in Own Shares | |
05 May 2005 | 04:45 PM | Director Shareholding | |
04 May 2005 | 07:00 AM | Cerovive | |
28 Apr 2005 | 04:55 PM | Result of AGM | |
28 Apr 2005 | 10:00 AM | 1st Quarter Results (2 of 2) | |
28 Apr 2005 | 10:00 AM | 1st Quarter Results (1 of 2) | |
27 Apr 2005 | 09:00 AM | Notice of Results | |
07 Apr 2005 | 04:00 PM | Director Shareholding | |
01 Apr 2005 | 02:30 PM | Nexium | |
31 Mar 2005 | 10:30 AM | Director Shareholding | |
29 Mar 2005 | 04:16 PM | Director Shareholding | |
29 Mar 2005 | 04:15 PM | Director Shareholding | |
23 Mar 2005 | 02:00 PM | Notice of AGM | |
21 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
18 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
17 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
15 Mar 2005 | 12:00 PM | Director Shareholding | |
14 Mar 2005 | 02:00 PM | Directorate Change | |
14 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
10 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
08 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
03 Mar 2005 | 04:00 PM | Holding(s) in Company | |
03 Mar 2005 | 04:00 PM | Holding(s) in Company | |
02 Mar 2005 | 07:00 AM | Transaction in Own Shares | |
01 Mar 2005 | 04:00 PM | Director Shareholding | |
28 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
25 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
24 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
23 Feb 2005 | 01:30 PM | Regulatory Approval | |
22 Feb 2005 | 11:08 AM | Annual Report and Accounts | |
21 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
15 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
14 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
11 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
10 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
07 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
04 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
02 Feb 2005 | 07:00 AM | Transaction in Own Shares | |
27 Jan 2005 | 11:00 AM | Final Results - Part 3 of 3 | |
27 Jan 2005 | 11:00 AM | Final Results - part 2 of 3 | |
27 Jan 2005 | 11:00 AM | Final Results - part 1 of 3 | |
26 Jan 2005 | 04:00 PM | Holding(s) in Company | |
26 Jan 2005 | 09:00 AM | Notice of Results | |
19 Jan 2005 | 02:30 PM | Statement re Exanta | |
17 Jan 2005 | 04:00 PM | Holding(s) in Company | |
17 Jan 2005 | 10:30 AM | Director Shareholding | |
04 Jan 2005 | 03:30 PM | Capital Group |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.